A Phase III Randomized Trial of MRI-Mapped, Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial

MAPS is the first phase III randomized trial of MRI-mapped, dose-escalated salvage radiotherapy. In this planned feasibility analysis, the researchers ensure dosimetric adequacy of the protocol as it relates to acute toxicity.

OncLive